DUPILUMAB

DUPILUMAB was reported 438499 times

DUPILUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 REBOUND ATOPIC DERMATITIS 2022 0.9966
1 REBOUND ECZEMA 2011 0.9858
2 DERMATITIS ATOPIC 41045 0.9111
3 EOSINOPHILIC OESOPHAGITIS 1587 0.6921
4 NEURODERMATITIS 2058 0.6686
5 PERIORBITAL IRRITATION 186 0.6370
6 EXPOSURE VIA SKIN CONTACT 11430 0.6076
7 SKIN WEEPING 1717 0.5714
8 ECZEMA EYELIDS 275 0.5522
9 EYELID SKIN DRYNESS 609 0.5491
10 ECZEMA 24172 0.5185
11 NASAL POLYPECTOMY 72 0.4832
12 PERIORBITAL INFLAMMATION 103 0.4747
13 CHRONIC RHINOSINUSITIS WITH NASAL POLYPS 57 0.4524
14 INJECTION SITE ECZEMA 74 0.4277
15 INJECTION SITE DRYNESS 351 0.4219
16 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 236 0.4155
17 NASAL POLYPS 1853 0.4127
18 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 5921 0.3970
19 EYELID RASH 347 0.3864
20 INJECTION SITE EXFOLIATION 243 0.3863
21 HAND DERMATITIS 232 0.3724
22 SKIN FISSURES 6460 0.3646
23 OCULAR SURFACE DISEASE 91 0.3640
24 PRODUCT DOSE OMISSION IN ERROR 9015 0.3624
25 LACK OF INJECTION SITE ROTATION 596 0.3612
26 MOOD DISORDER DUE TO A GENERAL MEDICAL CONDITION 71 0.3604
27 OESOPHAGEAL FOOD IMPACTION 156 0.3223
28 CONJUNCTIVITIS 5630 0.3181
29 PERIORAL DERMATITIS 181 0.3121
30 EYELID MARGIN CRUSTING 811 0.3050
31 EYELIDS PRURITUS 891 0.3023
32 EYE PRURITUS 9347 0.2979
33 SKIN SWELLING 2297 0.2847
34 SKIN HAEMORRHAGE 3843 0.2802
35 THERAPEUTIC RESPONSE SHORTENED 8204 0.2766
36 EYELID EXFOLIATION 209 0.2761
37 IMPAIRED QUALITY OF LIFE 3841 0.2745
38 DRY EYE 12355 0.2692
39 DYSHIDROTIC ECZEMA 168 0.2613
40 IDIOPATHIC URTICARIA 205 0.2528
41 CUTANEOUS T-CELL LYMPHOMA 280 0.2516
42 SKIN DISCOMFORT 619 0.2424
43 BLEPHARITIS 869 0.2297
44 REBOUND EFFECT 2508 0.2269
45 DERMATITIS 4417 0.2224
46 SCRATCH 2142 0.2169
47 ECZEMA NUMMULAR 88 0.2023
48 OFF LABEL USE OF DEVICE 242 0.2005
49 PERIORBITAL SWELLING 996 0.1902
50 KERATOCONUS 67 0.1898
51 NASAL OBSTRUCTION 327 0.1855
52 DRY SKIN 23316 0.1849
53 DRAINAGE 81 0.1837
54 ERYTHEMA OF EYELID 946 0.1835
55 EYE ALLERGY 271 0.1827
56 EYELID IRRITATION 428 0.1811
57 SWELLING OF EYELID 1049 0.1811
58 HORDEOLUM 717 0.1794
59 ECZEMA HERPETICUM 76 0.1759
60 EYE DISCHARGE 1725 0.1755
61 LACK OF ADMINISTRATION SITE ROTATION 49 0.1731
62 ORAL HERPES 3244 0.1724
63 OCULAR HYPERAEMIA 7576 0.1688
64 FACIAL DISCOMFORT 102 0.1669
65 SKIN EXFOLIATION 13299 0.1665
66 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 317 0.1656
67 ECZEMA ASTEATOTIC 75 0.1648
68 PRODUCT USE IN UNAPPROVED INDICATION 38078 0.1628
69 SKIN TEXTURE ABNORMAL 142 0.1583
70 MOLLUSCUM CONTAGIOSUM 80 0.1566
71 FEAR OF INJECTION 1023 0.1546
72 PRODUCT PREPARATION ERROR 3140 0.1544
73 INJECTION SITE URTICARIA 3532 0.1516
74 INJECTION SITE SWELLING 10951 0.1504
75 THERAPEUTIC RESPONSE DECREASED 8708 0.1490
76 RASH ERYTHEMATOUS 6582 0.1473
77 HYPOSMIA 205 0.1459
78 PRURITUS 52379 0.1449
79 ACTIVITIES OF DAILY LIVING DECREASED 52 0.1448
80 INFECTION PARASITIC 103 0.1441
81 INJECTION SITE VESICLES 824 0.1431
82 LIP ERYTHEMA 105 0.1417
83 ACCIDENTAL EXPOSURE TO PRODUCT 13305 0.1414
84 INJECTION SITE RASH 4067 0.1397
85 ASTHMA 14715 0.1363
86 HAND-FOOT-AND-MOUTH DISEASE 104 0.1345
87 CONJUNCTIVITIS ALLERGIC 186 0.1323
88 RASH MACULAR 4292 0.1273
89 LICHENIFICATION 49 0.1273
90 MILIARIA 205 0.1255
91 SKIN DEPIGMENTATION 166 0.1246
92 EYE IRRITATION 6249 0.1186
93 SINUS OPERATION 272 0.1182
94 ALLERGY TO ANIMAL 119 0.1172
95 INTERCEPTED PRODUCT STORAGE ERROR 378 0.1172
96 LACRIMATION INCREASED 3347 0.1164
97 SUPERFICIAL INJURY OF EYE 116 0.1130
98 INJECTION SITE PAIN 32857 0.1127
99 INTENTIONAL DOSE OMISSION 2789 0.1095
100 PRODUCT PRESCRIBING ISSUE 1958 0.1062
101 HYPEREOSINOPHILIC SYNDROME 54 0.1057
102 EYE INFLAMMATION 959 0.1055
103 DRUG EFFECT LESS THAN EXPECTED 1354 0.1044
104 NASAL OPERATION 67 0.1034
105 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 17346 0.1031
106 FOOD ALLERGY 738 0.1019
107 INJECTION SITE DISCOMFORT 998 0.1011
108 PUSTULE 216 0.0998
109 EYE ULCER 55 0.0996
110 EOSINOPHIL COUNT INCREASED 803 0.0995
111 PERIORBITAL PAIN 76 0.0978
112 EYE INFECTION 1038 0.0954
113 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 68 0.0948
114 KERATITIS 274 0.0944
115 SLEEP DISORDER 6277 0.0929
116 LIP PRURITUS 74 0.0927
117 SKIN EROSION 284 0.0925
118 INJECTION SITE INFLAMMATION 433 0.0908
119 EYELID PAIN 168 0.0895
120 TINEA INFECTION 95 0.0890
121 INJECTION SITE IRRITATION 1081 0.0886
122 INJECTION SITE PRURITUS 5621 0.0875
123 PRODUCT DOSE OMISSION ISSUE 23332 0.0874
124 DERMATITIS ALLERGIC 1045 0.0873
125 SEBORRHOEIC DERMATITIS 138 0.0867
126 PARANASAL SINUS DISCOMFORT 314 0.0864
127 ALCOHOL INTOLERANCE 59 0.0850
128 RASH 35570 0.0849
129 DISCHARGE 112 0.0845
130 INJECTION SITE ERYTHEMA 10065 0.0843
131 EOSINOPHIL COUNT ABNORMAL 60 0.0833
132 EXFOLIATIVE RASH 211 0.0827
133 EOSINOPHILIC PNEUMONIA 248 0.0818
134 SYMPTOM RECURRENCE 456 0.0817
135 ANOSMIA 1145 0.0813
136 SKIN WOUND 128 0.0809
137 UPPER-AIRWAY COUGH SYNDROME 638 0.0807
138 DISCOMFORT 4505 0.0771
139 HERPES OPHTHALMIC 96 0.0766
140 SENSITIVE SKIN 523 0.0764
141 SCAB 836 0.0763
142 PRODUCT USED FOR UNKNOWN INDICATION 91 0.0755
143 SKIN BURNING SENSATION 5084 0.0737
144 OCULAR DISCOMFORT 751 0.0728
145 NASAL CONGESTION 4116 0.0727
146 RASH PRURITIC 3787 0.0727
147 SKIN MASS 463 0.0726
148 INJECTION SITE DISCOLOURATION 867 0.0724
149 ROSACEA 322 0.0721
150 INJECTION SITE HYPOAESTHESIA 98 0.0721
151 ALLERGY TO CHEMICALS 87 0.0718
152 EYE SWELLING 2553 0.0712
153 SECRETION DISCHARGE 841 0.0711
154 EYE DISORDER 2254 0.0709
155 INJECTION SITE MASS 2488 0.0697
156 INJECTION SITE REACTION 4620 0.0695
157 RESPIRATION ABNORMAL 448 0.0681
158 CONDITION AGGRAVATED 19621 0.0673
159 CROUP INFECTIOUS 50 0.0672
160 NASAL INFLAMMATION 68 0.0667
161 SARS-COV-2 TEST POSITIVE 873 0.0664
162 INJECTION SITE BRUISING 5028 0.0664
163 FOREIGN BODY IN EYE 59 0.0650
164 SKIN HYPERTROPHY 175 0.0646
165 ALLERGIC SINUSITIS 53 0.0632
166 HYPERAESTHESIA TEETH 74 0.0630
167 ERYTHEMA 12524 0.0628
168 SENSITIVITY TO WEATHER CHANGE 308 0.0611
169 DANDRUFF 128 0.0602
170 RESPIRATORY TRACT CONGESTION 924 0.0599
171 SKIN WARM 338 0.0598
172 ACARODERMATITIS 65 0.0594
173 PRODUCT USE ISSUE 10648 0.0590
174 VITILIGO 131 0.0590
175 IMPETIGO 84 0.0584
176 NASAL DISCHARGE DISCOLOURATION 78 0.0581
177 INJECTION SITE PARAESTHESIA 85 0.0580
178 SKIN HYPOPIGMENTATION 99 0.0580
179 PIGMENTATION DISORDER 344 0.0575
180 PHARYNGITIS STREPTOCOCCAL 605 0.0574
181 INITIAL INSOMNIA 568 0.0574
182 T-CELL LYMPHOMA 62 0.0567
183 DERMATITIS PSORIASIFORM 112 0.0565
184 DERMATITIS EXFOLIATIVE GENERALISED 182 0.0558
185 ILLNESS 5264 0.0556
186 SNEEZING 1203 0.0555
187 ALOPECIA AREATA 95 0.0555
188 NOROVIRUS INFECTION 70 0.0550
189 LYMPHOCYTIC INFILTRATION 53 0.0550
190 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 875 0.0549
191 RHINORRHOEA 3404 0.0546
192 SKIN DISCOLOURATION 2434 0.0545
193 SKIN IRRITATION 2433 0.0544
194 EYE PAIN 2889 0.0543
195 FUNGAL SKIN INFECTION 207 0.0536
196 INCORRECT DOSE ADMINISTERED 11572 0.0535
197 SKIN ATROPHY 293 0.0527
198 WISDOM TEETH REMOVAL 66 0.0525
199 ASTHENOPIA 276 0.0524
200 CHAPPED LIPS 219 0.0518
201 FOREIGN BODY SENSATION IN EYES 311 0.0518
202 LIP EXFOLIATION 67 0.0517
203 GENERAL PHYSICAL CONDITION ABNORMAL 341 0.0515
204 DEVICE DISPENSING ERROR 59 0.0513
205 INJECTION SITE SCAR 138 0.0507
206 INJECTION SITE WARMTH 1016 0.0507
207 EYELID DISORDER 110 0.0492
208 WHEEZING 2787 0.0487
209 PAIN OF SKIN 1276 0.0486
210 PHARYNGEAL SWELLING 438 0.0479
211 SINUS PAIN 106 0.0478
212 SKIN DISORDER 1528 0.0475
213 DACRYOSTENOSIS ACQUIRED 60 0.0474
214 INJECTION SITE HYPERSENSITIVITY 138 0.0474
215 VISION BLURRED 6261 0.0473
216 BLEPHAROSPASM 277 0.0469
217 EXPOSURE TO SARS-COV-2 79 0.0467
218 STRESS AT WORK 51 0.0464
219 THROAT CLEARING 164 0.0460
220 MAST CELL ACTIVATION SYNDROME 56 0.0460
221 SERUM SICKNESS 123 0.0453
222 ODYNOPHAGIA 254 0.0446
223 OROPHARYNGEAL DISCOMFORT 382 0.0445
224 ARTHROPOD STING 71 0.0442
225 EAR INFECTION 1136 0.0442
226 SKIN TIGHTNESS 201 0.0441
227 ARTHRALGIA 17651 0.0440
228 SKIN PAPILLOMA 172 0.0440
229 SUNBURN 316 0.0436
230 COVID-19 7442 0.0430
231 RASH VESICULAR 199 0.0426
232 LICHEN PLANUS 95 0.0425
233 DARK CIRCLES UNDER EYES 61 0.0425
234 SKIN INDURATION 84 0.0419
235 PRODUCT DOSE OMISSION 2735 0.0418
236 EXTRA DOSE ADMINISTERED 1600 0.0418
237 SINUS DISORDER 799 0.0414
238 OTORRHOEA 70 0.0414
239 ORAL MUCOSAL ERUPTION 61 0.0412
240 EXPOSURE VIA BREAST MILK 152 0.0405
241 ERYTHEMA NODOSUM 138 0.0405
242 TOOTHACHE 708 0.0402
243 DERMATITIS CONTACT 443 0.0402
244 BLISTER 2184 0.0402
245 CORNEAL ABRASION 53 0.0399
246 ANKLE OPERATION 56 0.0398
247 NECK SURGERY 87 0.0396
248 RESPIRATORY SYNCYTIAL VIRUS INFECTION 324 0.0396
249 PRODUCTIVE COUGH 1802 0.0396
250 ARTHROPOD BITE 282 0.0395
251 CHEILITIS 203 0.0387
252 SHOULDER OPERATION 154 0.0382
253 NASAL DRYNESS 231 0.0380
254 INJECTION SITE OEDEMA 63 0.0379
255 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 213 0.0379
256 RHINALGIA 99 0.0378
257 EXCESSIVE EYE BLINKING 54 0.0377
258 SPINAL OPERATION 434 0.0376
259 SKIN WRINKLING 99 0.0376
260 COUGH 10199 0.0376
261 LIP BLISTER 100 0.0376
262 URTICARIA 6025 0.0375
263 EAR SWELLING 76 0.0373
264 PAROSMIA 273 0.0373
265 MIDDLE INSOMNIA 672 0.0372
266 SINUSITIS 3709 0.0371
267 DEVICE OPERATIONAL ISSUE 150 0.0369
268 SKIN ULCER 925 0.0369
269 SLEEP DEFICIT 71 0.0367
270 LIP DRY 313 0.0365
271 VITREOUS FLOATERS 342 0.0364
272 ROTATOR CUFF REPAIR 60 0.0360
273 HERPES VIRUS INFECTION 201 0.0359
274 INJECTION SITE DISCHARGE 163 0.0359
275 INCORRECT DOSE ADMINISTERED BY PRODUCT 49 0.0357
276 RESPIRATORY SYMPTOM 95 0.0354
277 PRODUCT PRESCRIBING ERROR 800 0.0353
278 MIDDLE EAR EFFUSION 75 0.0352
279 NASOPHARYNGITIS 6310 0.0352
280 PRODUCT STORAGE ERROR 2930 0.0350
281 RASH PAPULAR 762 0.0348
282 DEVICE USE ISSUE 582 0.0348
283 GENITAL HERPES 52 0.0348
284 SKIN STRIAE 50 0.0346
285 THERAPEUTIC RESPONSE DELAYED 94 0.0346
286 OROPHARYNGEAL PAIN 3095 0.0344
287 JOINT NOISE 64 0.0343
288 KNEE OPERATION 319 0.0342
289 SEASONAL ALLERGY 459 0.0340
290 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1551 0.0339
291 INJECTION SITE INDURATION 428 0.0339
292 STRESS 2341 0.0336
293 SKIN INFECTION 360 0.0333
294 HERNIA REPAIR 83 0.0331
295 EAR PRURITUS 111 0.0331
296 INFLUENZA 3584 0.0331
297 HYPOGEUSIA 63 0.0330
298 EOSINOPHIL COUNT DECREASED 73 0.0330
299 INJECTION SITE INDENTATION 60 0.0329
300 EYE OPERATION 141 0.0327
301 ORAL MUCOSAL ERYTHEMA 49 0.0326
302 SINUS HEADACHE 190 0.0326
303 STREPTOCOCCAL INFECTION 175 0.0324
304 ABNORMAL SENSATION IN EYE 134 0.0323
305 SKIN ABRASION 145 0.0322
306 SINUS CONGESTION 424 0.0322
307 APHTHOUS ULCER 235 0.0319
308 PHOTOPHOBIA 576 0.0318
309 SUSPECTED COVID-19 104 0.0318
310 SURGERY 1759 0.0316
311 SKIN LESION 829 0.0316
312 THERAPEUTIC RESPONSE UNEXPECTED 1383 0.0315
313 PARANASAL SINUS HYPERSECRETION 118 0.0313
314 RESPIRATORY TRACT INFECTION VIRAL 70 0.0313
315 LIP PAIN 87 0.0312
316 EAR DISCOMFORT 309 0.0311
317 FOOT OPERATION 147 0.0309
318 LIMB OPERATION 141 0.0309
319 CHRONIC SINUSITIS 111 0.0304
320 ATYPICAL PNEUMONIA 88 0.0304
321 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 522 0.0300
322 ULCERATIVE KERATITIS 79 0.0298
323 NASAL SEPTUM DEVIATION 56 0.0295
324 SKIN PLAQUE 241 0.0294
325 INJECTION SITE NODULE 313 0.0294
326 FACIAL PAIN 253 0.0293
327 VISUAL IMPAIRMENT 3441 0.0290
328 EOSINOPHILIA 490 0.0290
329 PHOTOSENSITIVITY REACTION 463 0.0290
330 JOINT STIFFNESS 732 0.0287
331 PEMPHIGOID 201 0.0283
332 UPPER RESPIRATORY TRACT CONGESTION 80 0.0281
333 HYPERSENSITIVITY 5042 0.0280
334 FURUNCLE 216 0.0280
335 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1416 0.0280
336 MYOPIA 64 0.0279
337 GASTROENTERITIS VIRAL 488 0.0278
338 MATERNAL EXPOSURE DURING BREAST FEEDING 104 0.0277
339 WEIGHT ABNORMAL 64 0.0277
340 SKIN HYPERPIGMENTATION 230 0.0276
341 NEEDLE ISSUE 751 0.0274
342 RESPIRATORY TRACT INFECTION 686 0.0273
343 EAR CONGESTION 71 0.0271
344 LYMPH NODE PAIN 49 0.0270
345 EYE CONTUSION 55 0.0270
346 SPUTUM INCREASED 54 0.0268
347 VIRAL INFECTION 859 0.0267
348 AFFECTIVE DISORDER 203 0.0267
349 NASAL DISORDER 69 0.0266
350 SCAR 444 0.0265
351 HAEMATOLOGICAL INFECTION 55 0.0258
352 ATTENTION DEFICIT HYPERACTIVITY DISORDER 102 0.0257
353 OXYGEN CONSUMPTION INCREASED 58 0.0257
354 UPPER RESPIRATORY TRACT INFECTION 1143 0.0255
355 INFECTIOUS MONONUCLEOSIS 56 0.0255
356 SHOULDER ARTHROPLASTY 64 0.0252
357 RHINITIS ALLERGIC 108 0.0251
358 EMERGENCY CARE 71 0.0251
359 LYMPHADENOPATHY 855 0.0248
360 BLOOD IMMUNOGLOBULIN E INCREASED 59 0.0248
361 ORAL PRURITUS 55 0.0248
362 MULTIPLE ALLERGIES 187 0.0246
363 SWELLING 2210 0.0244
364 PULMONARY PAIN 67 0.0244
365 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1344 0.0243
366 SWELLING FACE 1531 0.0243
367 BRAIN FOG 318 0.0242
368 THERAPEUTIC PRODUCT EFFECT DECREASED 1025 0.0240
369 HERPES SIMPLEX 151 0.0240
370 DECREASED ACTIVITY 249 0.0240
371 BURNING SENSATION 1634 0.0240
372 SPUTUM DISCOLOURED 219 0.0239
373 DEVICE DEFECTIVE 349 0.0237
374 TENDERNESS 242 0.0237
375 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 147 0.0237
376 SKIN LACERATION 246 0.0236
377 MUSCULOSKELETAL DISCOMFORT 394 0.0236
378 GALLBLADDER OPERATION 91 0.0235
379 EAR PAIN 445 0.0235
380 EXPOSURE TO TOXIC AGENT 74 0.0234
381 THERAPEUTIC PRODUCT EFFECT DELAYED 101 0.0234
382 DYSPNOEA 12782 0.0233
383 SKIN ODOUR ABNORMAL 88 0.0232
384 PAPULE 154 0.0230
385 INFLAMMATION 1140 0.0230
386 BLOOD BLISTER 70 0.0229
387 KNEE ARTHROPLASTY 460 0.0229
388 SKIN INJURY 73 0.0229
389 APHONIA 309 0.0228
390 FOOD POISONING 116 0.0227
391 FUNGAL INFECTION 729 0.0225
392 CATARACT OPERATION 129 0.0225
393 DYSPHAGIA 2055 0.0224
394 PRURITUS GENITAL 50 0.0224
395 BRONCHITIS 1619 0.0223
396 SKIN REACTION 304 0.0223
397 HERPES ZOSTER 1244 0.0222
398 QUALITY OF LIFE DECREASED 290 0.0221
399 POLYMYALGIA RHEUMATICA 66 0.0221
400 DRY THROAT 218 0.0221
401 MYALGIA 3611 0.0219
402 APPENDICECTOMY 75 0.0218
403 DRUG INEFFECTIVE 27750 0.0217
404 CONJUNCTIVAL HYPERAEMIA 75 0.0217
405 CHEST DISCOMFORT 2139 0.0217
406 SPINAL FUSION SURGERY 84 0.0216
407 INJECTION SITE HAEMORRHAGE 1646 0.0215
408 PRODUCT DISPENSING ISSUE 58 0.0213
409 ANIMAL BITE 54 0.0212
410 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1445 0.0211
411 RHINOVIRUS INFECTION 76 0.0210
412 PERIPHERAL SWELLING 3117 0.0210
413 FORMICATION 142 0.0208
414 INTENTIONAL PRODUCT MISUSE 1755 0.0208
415 EXPOSURE DURING PREGNANCY 1248 0.0206
416 ORAL MUCOSAL BLISTERING 128 0.0206
417 INJURY ASSOCIATED WITH DEVICE 394 0.0205
418 ENDODONTIC PROCEDURE 51 0.0205
419 HIP SURGERY 104 0.0204
420 MATERNAL EXPOSURE DURING PREGNANCY 1727 0.0203
421 CARDIAC OPERATION 166 0.0203
422 ACNE 1494 0.0201
423 MATERNAL EXPOSURE TIMING UNSPECIFIED 72 0.0200
424 LOSS OF THERAPEUTIC RESPONSE 56 0.0199
425 HYPERKERATOSIS 107 0.0199
426 LIGAMENT SPRAIN 190 0.0198
427 ONYCHOMYCOSIS 84 0.0198
428 GINGIVAL PAIN 153 0.0198
429 MUSCLE STRAIN 166 0.0198
430 DERMATITIS ACNEIFORM 115 0.0197
431 INCORRECT DOSAGE ADMINISTERED 94 0.0197
432 HOSPITALISATION 2872 0.0196
433 DECREASED INTEREST 113 0.0196
434 REGURGITATION 64 0.0195
435 UNEVALUABLE EVENT 1423 0.0193
436 CONCUSSION 144 0.0192
437 HYPERPHAGIA 72 0.0192
438 ONYCHOCLASIS 126 0.0189
439 HYSTERECTOMY 156 0.0187
440 IMMUNE SYSTEM DISORDER 237 0.0186
441 PRODUCT TEMPERATURE EXCURSION ISSUE 83 0.0185
442 PSORIASIS 2335 0.0184
443 TRICHORRHEXIS 50 0.0184
444 ACCIDENT 210 0.0182
445 ALOPECIA 3470 0.0181
446 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 514 0.0181
447 LIMB INJURY 475 0.0181
448 POLYMENORRHOEA 57 0.0181
449 THROAT TIGHTNESS 474 0.0181
450 LARYNGITIS 190 0.0180
451 LOCALISED INFECTION 423 0.0180
452 LYME DISEASE 58 0.0180
453 NERVE COMPRESSION 160 0.0179
454 INFECTION 2499 0.0179
455 WEIGHT INCREASED 3824 0.0178
456 LIP SWELLING 573 0.0178
457 RHINITIS 139 0.0177
458 OESOPHAGEAL DISORDER 66 0.0175
459 BACK DISORDER 276 0.0174
460 MENSTRUAL DISORDER 137 0.0172
461 EAR DISORDER 77 0.0171
462 THROAT IRRITATION 736 0.0170
463 ARTHRITIS 1299 0.0170
464 DYSPNOEA EXERTIONAL 615 0.0169
465 NODULE 215 0.0169
466 TRIGGER FINGER 66 0.0168
467 CONTUSION 1560 0.0167
468 GASTRITIS 426 0.0166
469 CHEMOTHERAPY 58 0.0165
470 AUTOIMMUNE DISORDER 150 0.0164
471 SARCOIDOSIS 76 0.0164
472 HAND FRACTURE 113 0.0164
473 HIP ARTHROPLASTY 239 0.0163
474 MOOD ALTERED 425 0.0161
475 HAIR GROWTH ABNORMAL 108 0.0161
476 LIMB DISCOMFORT 481 0.0160
477 INJECTION SITE INJURY 83 0.0159
478 AUTOIMMUNE THYROIDITIS 58 0.0159
479 TEMPERATURE INTOLERANCE 157 0.0159
480 CARDIAC PACEMAKER INSERTION 92 0.0158
481 NAIL DISCOLOURATION 60 0.0158
482 STAPHYLOCOCCAL INFECTION 506 0.0157
483 CORONAVIRUS INFECTION 102 0.0157
484 CATARACT 899 0.0157
485 GLAUCOMA 293 0.0156
486 CHOKING 290 0.0154
487 PAIN IN EXTREMITY 4421 0.0154
488 MOUTH SWELLING 85 0.0153
489 NASAL DISCOMFORT 119 0.0153
490 ORAL PAIN 334 0.0153
491 DYSPHONIA 865 0.0152
492 PARAESTHESIA 2328 0.0152
493 OFF LABEL USE 12593 0.0151
494 BRONCHIECTASIS 96 0.0150
495 TONSILLITIS 75 0.0148
496 WOUND 396 0.0147
497 PHOTOPSIA 90 0.0147
498 INSOMNIA 3798 0.0146
499 MIGRAINE 1333 0.0146
500 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 638 0.0145
501 PAIN 8699 0.0145
502 BACK INJURY 151 0.0144
503 SCIATICA 221 0.0144
504 TOOTH INFECTION 184 0.0143
505 AGEUSIA 349 0.0143
506 DRUG HYPERSENSITIVITY 2718 0.0143
507 NEURALGIA 336 0.0143
508 POLYP 91 0.0143
509 MENISCUS INJURY 85 0.0142
510 MENTAL STATUS CHANGES 385 0.0142
511 MACULAR DEGENERATION 164 0.0142
512 SNORING 52 0.0142
513 GINGIVAL SWELLING 61 0.0142
514 HYPOAESTHESIA 2061 0.0141
515 INJECTION SITE EXTRAVASATION 173 0.0141
516 FEELING HOT 843 0.0141
517 HEADACHE 8540 0.0140
518 GAIT INABILITY 446 0.0140
519 EYE HAEMORRHAGE 182 0.0139
520 TASTE DISORDER 265 0.0139
521 ANKLE FRACTURE 209 0.0138
522 BLOOD PRESSURE ABNORMAL 264 0.0138
523 POST PROCEDURAL INFECTION 108 0.0138
524 RASH PUSTULAR 98 0.0137
525 IMMUNE THROMBOCYTOPENIA 58 0.0136
526 CHOLECYSTECTOMY 149 0.0135
527 PYREXIA 4538 0.0135
528 INCORRECT DOSE ADMINISTERED BY DEVICE 321 0.0134
529 JOINT SWELLING 1558 0.0133
530 CYST 160 0.0132
531 RESPIRATORY DISORDER 383 0.0131
532 EPISTAXIS 952 0.0131
533 TONGUE DISCOMFORT 53 0.0130
534 NAIL DISORDER 109 0.0130
535 HEAVY MENSTRUAL BLEEDING 96 0.0130
536 CHOKING SENSATION 69 0.0129
537 PULMONARY CONGESTION 167 0.0129
538 SPINAL STENOSIS 50 0.0128
539 INCREASED APPETITE 226 0.0128
540 INFLUENZA LIKE ILLNESS 1030 0.0128
541 PARAESTHESIA ORAL 177 0.0127
542 CANDIDA INFECTION 203 0.0127
543 RETCHING 259 0.0126
544 PSYCHIATRIC SYMPTOM 90 0.0125
545 GOUT 218 0.0125
546 VASCULITIS 141 0.0125
547 NECK PAIN 677 0.0124
548 PHARYNGITIS 151 0.0124
549 MENTAL DISORDER 521 0.0123
550 HEAD DISCOMFORT 208 0.0122
551 PURULENT DISCHARGE 51 0.0122
552 MUSCLE TIGHTNESS 192 0.0122
553 INCORRECT PRODUCT ADMINISTRATION DURATION 240 0.0122
554 STENT PLACEMENT 95 0.0122
555 POOR QUALITY PRODUCT ADMINISTERED 118 0.0121
556 THERMAL BURN 84 0.0121
557 PNEUMONIA 3793 0.0121
558 TENDONITIS 183 0.0120
559 BACK PAIN 2718 0.0120
560 BLOOD IRON DECREASED 136 0.0120
561 HERNIA 222 0.0119
562 BACTERIAL INFECTION 212 0.0118
563 UPPER LIMB FRACTURE 230 0.0118
564 PULMONARY FUNCTION TEST DECREASED 50 0.0117
565 ANAPHYLACTIC REACTION 619 0.0117
566 RETINAL DETACHMENT 104 0.0116
567 ROAD TRAFFIC ACCIDENT 473 0.0116
568 INCREASED TENDENCY TO BRUISE 104 0.0115
569 PURPURA 99 0.0115
570 JOINT INJURY 238 0.0114
571 ULCER 177 0.0114
572 FOOT FRACTURE 210 0.0113
573 GROIN PAIN 97 0.0113
574 DRY MOUTH 886 0.0113
575 LOWER LIMB FRACTURE 207 0.0113
576 PULMONARY MASS 162 0.0112
577 WRIST FRACTURE 131 0.0112
578 RIB FRACTURE 224 0.0112
579 MUSCULOSKELETAL STIFFNESS 957 0.0112
580 NEPHROLITHIASIS 495 0.0112
581 DEPRESSED MOOD 570 0.0112
582 PETECHIAE 112 0.0112
583 ABDOMINAL PAIN UPPER 2216 0.0111
584 TOOTH EXTRACTION 135 0.0111
585 VULVOVAGINAL PRURITUS 54 0.0111
586 DIVERTICULITIS 297 0.0111
587 MADAROSIS 127 0.0111
588 SLEEP APNOEA SYNDROME 206 0.0110
589 BONE PAIN 626 0.0110
590 KIDNEY INFECTION 210 0.0110
591 URINARY TRACT INFECTION 1817 0.0110
592 CARDIAC FLUTTER 69 0.0110
593 PNEUMONIA BACTERIAL 96 0.0109
594 CELLULITIS 534 0.0109
595 ORAL DISCOMFORT 147 0.0108
596 INTRAOCULAR PRESSURE INCREASED 135 0.0108
597 ABDOMINAL DISCOMFORT 1712 0.0106
598 COVID-19 PNEUMONIA 122 0.0105
599 EATING DISORDER 217 0.0104
600 GASTROOESOPHAGEAL REFLUX DISEASE 806 0.0104
601 LUNG DISORDER 492 0.0104
602 SENSATION OF FOREIGN BODY 84 0.0103
603 CARPAL TUNNEL SYNDROME 141 0.0103
604 GINGIVITIS 54 0.0103
605 MOUTH ULCERATION 209 0.0102
606 VERTIGO 607 0.0102
607 GLUCOSE TOLERANCE IMPAIRED 58 0.0102
608 AUTISM SPECTRUM DISORDER 54 0.0102
609 CHEST PAIN 1840 0.0102
610 DIZZINESS POSTURAL 94 0.0102
611 FATIGUE 7621 0.0101
612 DECREASED IMMUNE RESPONSIVENESS 95 0.0101
613 ANEURYSM 49 0.0101
614 POLYARTHRITIS 51 0.0100
615 LYMPHOEDEMA 67 0.0100
616 FOLLICULITIS 99 0.0100
617 ROTATOR CUFF SYNDROME 126 0.0100
618 VITAMIN D DECREASED 83 0.0100
619 GRIP STRENGTH DECREASED 84 0.0099
620 MUSCULOSKELETAL CHEST PAIN 149 0.0099
621 IMMUNODEFICIENCY 139 0.0098
622 DIZZINESS 4730 0.0098
623 OESOPHAGITIS 104 0.0098
624 MUSCLE SPASMS 1739 0.0097
625 MENSTRUATION DELAYED 99 0.0097
626 PAIN IN JAW 269 0.0097
627 NERVE INJURY 105 0.0097
628 DIPLOPIA 240 0.0095
629 HYPOACUSIS 397 0.0095
630 IMMUNOSUPPRESSION 79 0.0095
631 ORAL DISORDER 68 0.0095
632 HEART RATE ABNORMAL 51 0.0095
633 OVERWEIGHT 49 0.0094
634 LYMPHOMA 142 0.0094
635 GASTROINTESTINAL DISORDER 792 0.0094
636 CYSTIC FIBROSIS 51 0.0094
637 BOWEL MOVEMENT IRREGULARITY 68 0.0093
638 SWOLLEN TONGUE 282 0.0093
639 BLINDNESS TRANSIENT 66 0.0092
640 SLUGGISHNESS 91 0.0092
641 EMPHYSEMA 91 0.0092
642 HYPERHIDROSIS 1155 0.0092
643 PSEUDOMONAS INFECTION 75 0.0092
644 PRODUCT DISPENSING ERROR 194 0.0092
645 HYPOKINESIA 129 0.0091
646 EMOTIONAL DISORDER 277 0.0091
647 PLEURISY 53 0.0091
648 ORAL CANDIDIASIS 113 0.0090
649 POOR QUALITY SLEEP 186 0.0090
650 CHILLS 1019 0.0089
651 HYPERSOMNIA 246 0.0088
652 TOOTH ABSCESS 88 0.0088
653 FLUSHING 876 0.0088
654 ARTHROPATHY 475 0.0087
655 NIGHT SWEATS 272 0.0087
656 SKIN CANCER 182 0.0087
657 HYPOAESTHESIA ORAL 127 0.0087
658 GAIT DISTURBANCE 1623 0.0087
659 FEEDING DISORDER 164 0.0087
660 STOMATITIS 505 0.0086
661 URINE ODOUR ABNORMAL 49 0.0085
662 NEOPLASM MALIGNANT 549 0.0085
663 OXYGEN SATURATION DECREASED 456 0.0085
664 MALAISE 3604 0.0084
665 FRUSTRATION TOLERANCE DECREASED 65 0.0084
666 GASTROINTESTINAL PAIN 89 0.0084
667 SCREAMING 52 0.0083
668 HIP FRACTURE 258 0.0083
669 ADVERSE DRUG REACTION 714 0.0083
670 VISUAL FIELD DEFECT 58 0.0082
671 BLINDNESS UNILATERAL 111 0.0081
672 MUSCLE DISORDER 64 0.0081
673 FIBROMYALGIA 189 0.0080
674 MEMORY IMPAIRMENT 1070 0.0080
675 HEAD INJURY 244 0.0080
676 WEIGHT FLUCTUATION 80 0.0080
677 HOSPICE CARE 76 0.0080
678 BREAST MASS 52 0.0080
679 UVEITIS 103 0.0079
680 BREAST CANCER FEMALE 207 0.0078
681 APPENDICITIS 70 0.0078
682 HEREDITARY ANGIOEDEMA 78 0.0078
683 SQUAMOUS CELL CARCINOMA 71 0.0077
684 DRUG ERUPTION 132 0.0077
685 BURSITIS 90 0.0077
686 FEELING ABNORMAL 1804 0.0077
687 COLD SWEAT 132 0.0077
688 FALL 2474 0.0077
689 EYE MOVEMENT DISORDER 51 0.0076
690 PULMONARY THROMBOSIS 81 0.0076
691 TENDON PAIN 56 0.0076
692 MUSCLE TWITCHING 170 0.0076
693 WEIGHT DECREASED 2042 0.0075
694 HYPERAESTHESIA 61 0.0075
695 CYSTITIS 233 0.0075
696 IMPAIRED DRIVING ABILITY 82 0.0074
697 CRYING 263 0.0074
698 HEART RATE INCREASED 706 0.0074
699 PRESYNCOPE 172 0.0073
700 PANIC ATTACK 261 0.0073
701 ANXIETY 2035 0.0073
702 PERIPHERAL COLDNESS 98 0.0073
703 EYELID PTOSIS 72 0.0073
704 ABSCESS 113 0.0073
705 LETHARGY 407 0.0073
706 JOINT DISLOCATION 74 0.0072
707 SENSORY DISTURBANCE 114 0.0072
708 GENERALISED OEDEMA 86 0.0072
709 DYSPEPSIA 684 0.0072
710 ABDOMINAL DISTENSION 720 0.0072
711 THYROID DISORDER 107 0.0072
712 GASTROINTESTINAL INFECTION 62 0.0072
713 INTERVERTEBRAL DISC PROTRUSION 153 0.0071
714 EYELID OEDEMA 82 0.0071
715 FEELING COLD 193 0.0071
716 IMPAIRED GASTRIC EMPTYING 81 0.0071
717 FACIAL PARALYSIS 57 0.0070
718 HIATUS HERNIA 88 0.0070
719 PROCEDURAL PAIN 186 0.0069
720 GALLBLADDER DISORDER 121 0.0069
721 LEUKAEMIA 63 0.0069
722 THERAPY CESSATION 338 0.0068
723 OBSTRUCTIVE AIRWAYS DISORDER 74 0.0068
724 WHITE BLOOD CELL COUNT INCREASED 255 0.0068
725 IMPAIRED WORK ABILITY 142 0.0068
726 SYSTEMIC LUPUS ERYTHEMATOSUS 232 0.0068
727 PELVIC FRACTURE 51 0.0068
728 CARDIAC DISORDER 618 0.0067
729 BRONCHOSPASM 94 0.0067
730 BEDRIDDEN 86 0.0067
731 TINNITUS 301 0.0067
732 MENSTRUATION IRREGULAR 174 0.0067
733 THERAPY INTERRUPTED 433 0.0067
734 DEPRESSION 1493 0.0067
735 BLOOD SODIUM DECREASED 122 0.0067
736 PNEUMOTHORAX 102 0.0066
737 LOWER RESPIRATORY TRACT INFECTION 287 0.0066
738 MOVEMENT DISORDER 206 0.0066
739 TOOTH DISORDER 143 0.0065
740 DIARRHOEA 4057 0.0065
741 HAEMORRHAGE 659 0.0065
742 DEVICE ISSUE 542 0.0065
743 DYSSTASIA 185 0.0065
744 MOBILITY DECREASED 449 0.0065
745 HELICOBACTER INFECTION 63 0.0064
746 IRRITABILITY 378 0.0064
747 FLATULENCE 349 0.0064
748 HOT FLUSH 469 0.0064
749 PRODUCT ADMINISTRATION ERROR 122 0.0064
750 MASS 86 0.0063
751 NAUSEA 4782 0.0063
752 THROMBOSIS 492 0.0063
753 NERVOUSNESS 318 0.0062
754 HIDRADENITIS 50 0.0062
755 HUNGER 76 0.0062
756 FULL BLOOD COUNT ABNORMAL 63 0.0062
757 BLINDNESS 243 0.0062
758 THIRST 106 0.0061
759 RESTLESS LEGS SYNDROME 109 0.0061
760 DEMENTIA 164 0.0061
761 FLUID RETENTION 302 0.0061
762 ABORTION SPONTANEOUS 239 0.0061
763 TRANSIENT ISCHAEMIC ATTACK 200 0.0061
764 SPINAL PAIN 68 0.0060
765 COELIAC DISEASE 57 0.0060
766 SPINAL DISORDER 55 0.0060
767 ERUCTATION 106 0.0059
768 MUSCULAR WEAKNESS 655 0.0059
769 BREAST PAIN 61 0.0059
770 HEART RATE IRREGULAR 130 0.0059
771 VOMITING 2654 0.0058
772 DECREASED APPETITE 1302 0.0058
773 BODY TEMPERATURE INCREASED 116 0.0058
774 POLLAKIURIA 232 0.0057
775 BRAIN NEOPLASM 51 0.0057
776 IRRITABLE BOWEL SYNDROME 118 0.0057
777 NO ADVERSE EVENT 976 0.0057
778 COLITIS 205 0.0056
779 EXOSTOSIS 50 0.0056
780 ERYTHEMA MULTIFORME 51 0.0056
781 NEUROPATHY PERIPHERAL 513 0.0056
782 ATRIAL FIBRILLATION 531 0.0056
783 OVARIAN CYST 55 0.0056
784 MALIGNANT MELANOMA 73 0.0056
785 ADVERSE REACTION 71 0.0055
786 RENAL DISORDER 250 0.0055
787 BLOOD URINE PRESENT 102 0.0055
788 CEREBROVASCULAR ACCIDENT 911 0.0055
789 ASTHENIA 2005 0.0055
790 LOSS OF CONSCIOUSNESS 685 0.0055
791 TREATMENT FAILURE 434 0.0055
792 SYNCOPE 530 0.0054
793 POST PROCEDURAL COMPLICATION 102 0.0054
794 PALPITATIONS 611 0.0054
795 TOOTH FRACTURE 58 0.0054
796 WOUND INFECTION 56 0.0054
797 FEELING JITTERY 99 0.0053
798 SPINAL FRACTURE 102 0.0053
799 DIALYSIS 73 0.0053
800 RENAL PAIN 54 0.0052
801 HYPERTENSION 1081 0.0052
802 ADRENAL INSUFFICIENCY 60 0.0052
803 HAEMOPTYSIS 141 0.0052
804 DIABETES MELLITUS 387 0.0052
805 DYSURIA 184 0.0051
806 INTERNAL HAEMORRHAGE 57 0.0051
807 PERICARDIAL EFFUSION 114 0.0051
808 ABDOMINAL PAIN 1150 0.0051
809 IMPAIRED HEALING 161 0.0050
810 OSTEOPOROSIS 202 0.0050
811 GINGIVAL BLEEDING 67 0.0050
812 INFUSION SITE PAIN 62 0.0050
813 HAIR TEXTURE ABNORMAL 66 0.0050
814 OSTEOARTHRITIS 206 0.0050
815 SOMNOLENCE 959 0.0049
816 LEUKOCYTOSIS 86 0.0049
817 PULMONARY OEDEMA 214 0.0049
818 GLOSSODYNIA 106 0.0049
819 TENDON RUPTURE 59 0.0049
820 GLYCOSYLATED HAEMOGLOBIN INCREASED 118 0.0048
821 BLOOD PRESSURE INCREASED 718 0.0048
822 BLOOD POTASSIUM DECREASED 141 0.0048
823 DENTAL CARIES 52 0.0048
824 ANGIOEDEMA 206 0.0048
825 DISTURBANCE IN ATTENTION 253 0.0048
826 AMENORRHOEA 78 0.0048
827 CONSTIPATION 998 0.0048
828 DRUG DOSE OMISSION BY DEVICE 346 0.0047
829 MOOD SWINGS 147 0.0047
830 COLON CANCER 68 0.0047
831 INJECTION SITE HAEMATOMA 67 0.0046
832 NEOPLASM 52 0.0046
833 BALANCE DISORDER 391 0.0046
834 TUBERCULOSIS 58 0.0046
835 PSORIATIC ARTHROPATHY 179 0.0046
836 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 900 0.0046
837 CLOSTRIDIUM DIFFICILE INFECTION 96 0.0046
838 BIPOLAR DISORDER 49 0.0046
839 DEAFNESS 116 0.0046
840 SPEECH DISORDER 231 0.0045
841 BLOOD CHOLESTEROL INCREASED 205 0.0045
842 GASTROENTERITIS 64 0.0045
843 CHROMATURIA 99 0.0045
844 DEVICE LEAKAGE 180 0.0045
845 FRACTURE 82 0.0044
846 SEIZURE 491 0.0044
847 PERICARDITIS 71 0.0044
848 DEHYDRATION 568 0.0044
849 BLOOD GLUCOSE ABNORMAL 78 0.0043
850 DYSMENORRHOEA 54 0.0043
851 PANCREATITIS 217 0.0042
852 PNEUMONITIS 110 0.0042
853 LUNG NEOPLASM MALIGNANT 170 0.0042
854 RHEUMATOID ARTHRITIS 461 0.0042
855 GENERAL PHYSICAL HEALTH DETERIORATION 465 0.0042
856 FREQUENT BOWEL MOVEMENTS 107 0.0041
857 COLITIS ULCERATIVE 177 0.0041
858 ANGER 136 0.0041
859 FAECES DISCOLOURED 86 0.0041
860 HEPATIC STEATOSIS 73 0.0041
861 CONTRAINDICATED PRODUCT ADMINISTERED 118 0.0040
862 ANAPHYLACTIC SHOCK 100 0.0040
863 TREATMENT NONCOMPLIANCE 212 0.0040
864 RESTLESSNESS 143 0.0040
865 OEDEMA 210 0.0040
866 PALLOR 106 0.0040
867 PRODUCT USE COMPLAINT 58 0.0039
868 DEVICE MALFUNCTION 248 0.0039
869 OSTEOMYELITIS 69 0.0039
870 ANKYLOSING SPONDYLITIS 49 0.0039
871 INSURANCE ISSUE 53 0.0039
872 BASAL CELL CARCINOMA 58 0.0038
873 TREMOR 615 0.0038
874 BLOOD PRESSURE DECREASED 242 0.0038
875 SYRINGE ISSUE 64 0.0037
876 HEART RATE DECREASED 128 0.0037
877 HYPERTHYROIDISM 52 0.0037
878 ABNORMAL DREAMS 101 0.0037
879 MUSCULOSKELETAL DISORDER 69 0.0037
880 PRURITUS GENERALISED 79 0.0036
881 GASTRIC ULCER 67 0.0036
882 THERAPY NON-RESPONDER 153 0.0036
883 FACE OEDEMA 59 0.0036
884 ERECTILE DYSFUNCTION 89 0.0036
885 HAEMATOMA 90 0.0035
886 CARDIAC FAILURE CONGESTIVE 281 0.0035
887 MYOCARDIAL INFARCTION 593 0.0034
888 SEPSIS 373 0.0034
889 BLOOD POTASSIUM INCREASED 54 0.0034
890 AMNESIA 214 0.0034
891 HEPATIC ENZYME INCREASED 221 0.0034
892 URINARY INCONTINENCE 96 0.0033
893 APHASIA 98 0.0033
894 HAEMORRHOIDS 63 0.0033
895 OEDEMA PERIPHERAL 391 0.0033
896 HYPOXIA 109 0.0032
897 HAEMATOCHEZIA 171 0.0032
898 BLOOD GLUCOSE DECREASED 149 0.0032
899 DISEASE RECURRENCE 147 0.0032
900 LIVER FUNCTION TEST INCREASED 64 0.0031
901 BONE DISORDER 56 0.0031
902 ILL-DEFINED DISORDER 183 0.0031
903 RESPIRATORY DISTRESS 83 0.0031
904 MUSCULOSKELETAL PAIN 159 0.0031
905 NIGHTMARE 103 0.0030
906 LIVER DISORDER 127 0.0029
907 RASH MACULO-PAPULAR 63 0.0029
908 CHOLELITHIASIS 92 0.0029
909 RASH GENERALISED 75 0.0029
910 TACHYCARDIA 248 0.0029
911 INTESTINAL OBSTRUCTION 103 0.0029
912 C-REACTIVE PROTEIN INCREASED 100 0.0028
913 NERVOUS SYSTEM DISORDER 86 0.0028
914 DYSGEUSIA 204 0.0028
915 DYSARTHRIA 102 0.0028
916 THINKING ABNORMAL 51 0.0028
917 CARDIAC FAILURE 217 0.0028
918 HEPATIC CIRRHOSIS 50 0.0028
919 PULMONARY FIBROSIS 51 0.0028
920 INJURY 189 0.0027
921 ABDOMINAL PAIN LOWER 67 0.0027
922 DISABILITY 51 0.0027
923 MENTAL IMPAIRMENT 63 0.0027
924 DEVICE DELIVERY SYSTEM ISSUE 65 0.0027
925 DRUG INTOLERANCE 244 0.0026
926 TYPE 2 DIABETES MELLITUS 86 0.0026
927 DEVICE USE ERROR 85 0.0026
928 HYPOTHYROIDISM 80 0.0026
929 DEVICE DIFFICULT TO USE 165 0.0026
930 PULMONARY HYPERTENSION 52 0.0025
931 FEMUR FRACTURE 76 0.0025
932 GASTRIC DISORDER 86 0.0025
933 INTENTIONAL PRODUCT USE ISSUE 213 0.0025
934 EXPIRED PRODUCT ADMINISTERED 80 0.0025
935 HYPOTENSION 481 0.0025
936 DISORIENTATION 95 0.0024
937 BLOOD GLUCOSE INCREASED 449 0.0024
938 ANGINA PECTORIS 68 0.0024
939 URINARY RETENTION 77 0.0024
940 RED BLOOD CELL COUNT DECREASED 66 0.0024
941 PLEURAL EFFUSION 139 0.0023
942 MULTIPLE SCLEROSIS 103 0.0022
943 BLOOD PRESSURE FLUCTUATION 51 0.0022
944 UNDERDOSE 154 0.0022
945 BREAST CANCER 199 0.0022
946 PULMONARY EMBOLISM 200 0.0021
947 CONFUSIONAL STATE 337 0.0021
948 ADVERSE EVENT 191 0.0021
949 ARRHYTHMIA 98 0.0021
950 CEREBRAL HAEMORRHAGE 72 0.0021
951 AGITATION 148 0.0021
952 CARDIOVASCULAR DISORDER 51 0.0020
953 PROSTATE CANCER 160 0.0020
954 EPILEPSY 59 0.0020
955 RENAL IMPAIRMENT 161 0.0020
956 VISUAL ACUITY REDUCED 64 0.0019
957 RESPIRATORY FAILURE 137 0.0019
958 HALLUCINATION 139 0.0019
959 RECTAL HAEMORRHAGE 76 0.0018
960 ANAEMIA 322 0.0017
961 LABORATORY TEST ABNORMAL 49 0.0017
962 ABNORMAL BEHAVIOUR 66 0.0017
963 DYSKINESIA 66 0.0017
964 DEEP VEIN THROMBOSIS 103 0.0016
965 WHITE BLOOD CELL COUNT DECREASED 167 0.0016
966 SUICIDAL IDEATION 139 0.0016
967 COGNITIVE DISORDER 69 0.0015
968 WITHDRAWAL SYNDROME 63 0.0015
969 DRUG DOSE OMISSION 252 0.0015
970 ACCIDENTAL OVERDOSE 54 0.0015
971 HAEMOGLOBIN DECREASED 149 0.0015
972 DEATH 1174 0.0014
973 AGGRESSION 68 0.0014
974 HYPERGLYCAEMIA 49 0.0014
975 PLATELET COUNT DECREASED 142 0.0014
976 RENAL FAILURE 179 0.0014
977 DRUG INTERACTION 207 0.0013
978 DEVICE BREAKAGE 49 0.0013
979 VAGINAL HAEMORRHAGE 51 0.0012
980 INTERSTITIAL LUNG DISEASE 57 0.0012
981 EMOTIONAL DISTRESS 134 0.0011
982 GASTROINTESTINAL HAEMORRHAGE 89 0.0011
983 CHRONIC KIDNEY DISEASE 81 0.0011
984 BRADYCARDIA 50 0.0010
985 FOETAL EXPOSURE DURING PREGNANCY 76 0.0010
986 DISEASE PROGRESSION 109 0.0010
987 CARDIAC ARREST 76 0.0009
988 BLOOD CREATININE INCREASED 57 0.0009
989 INFUSION RELATED REACTION 52 0.0008
990 THROMBOCYTOPENIA 63 0.0006
991 NEUTROPENIA 69 0.0005
992 ACUTE KIDNEY INJURY 74 0.0005
993 OVERDOSE 63 0.0003